Next user fee deal reveals where industry won at the negotiating table with FDA

Every five years, the way the FDA and the biopharma industry interact changes, sometimes more than a little bit. While the tried and true processes of drugmaker-FDA interactions remain intact, industry and the FDA spend months at the negotiating table hashing out new ways to alter their interactions and allow

Read the full article here

Related Articles